Mechanism research of Tbx3 gene in tumor progression

Abstract

Shan Zezhi, Yan Xuebing, Tian Yuan, Jin Zhiming. Mechanism research of Tbx3 gene in tumor progression[J]. Journal of International Oncology, 2015, 42(1): 37-39.

［1］ Washkowitz AJ, Gavrilov S, Begum S, et al. Diverse functional networks of Tbx3 in development and disease［J］. Wiley Interdiscip Rev Syst Biol Med, 2012, 4(3): 273-283. ［2］ Gavrilov S, Harvey RP, Papaioannou VE. Lack of genetic interaction between Tbx20 and Tbx3 in early mouse heart development［J］. PLoS One, 2013, 8(7): e70149. ［3］ Douglas NC, Papaioannou VE. The Tbox transcription factors TBX2 and TBX3 in mammary gland development and breast cancer［J］. J Mammary Gland Biol Neoplasia, 2013, 18(2): 143-147. ［4］ Ballim RD, Mendelsohn C, Papaioannou VE, et al. The ulnarmammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development［J］. Mol Biol Cell, 2012, 23(12): 2362-2372. ［5］ Hoogaars WM, Engel A, Brons JF, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria［J］. Genes Dev, 2007, 21(9): 1098-1112. ［6］ Lu R, Yang A, Jin Y. Dual functions of Tbox 3 (Tbx3) in the control of selfrenewal and extraembryonic endoderm differentiation in mouse embryonic stem cells［J］. J Biol Chem, 2011, 286(10): 8425-8436. ［7］ Weidgang CE, Russell R, Tata PR, et al. TBX3 directs cellfate decision toward mesendoderm［J］. Stem Cell Reports, 2013, 1(3): 248265. ［8］ Guo F, Parker Kerrigan BC, Yang D, et al. Posttranscriptional regulatory network of epithelialtomesenchymal and mesenchymaltoepithelial transitions［J］. J Hematol Oncol, 2014, 7: 19. ［9］ Rodriguez M, Aladowicz E, Lanfrancone L, et al. Tbx3 represses Ecadherin expression and enhances melanoma invasiveness［J］. Cancer Res, 2008, 68(19): 7872-7881. ［10］ Boyd SC, Mijatov B, Pupo GM, et al. Oncogenic BRAF(V600E) signaling induces the TBox3 transcriptional repressor to repress Ecadherin and enhance melanoma cell invasion［J］. J Invest Dermatol, 2013, 133(5): 12691277. ［11］ Du HF, Ou LP, Yang X, et al. A new PKCα/β/TBX3/Ecadherin pathway is involved in PLCεregulated invasion and migration in human bladder cancer cells［J］. Cell Signal, 2014, 26(3): 580-593. ［12］ Yu Z, Pestell TG, Lisanti MP, et al. Cancer stem cells［J］. Int J Biochem Cell Biol, 2012, 44(12): 2144-2151. ［13］ Amini S, Fathi F, Mobalegi J, et al. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines［J］. Anat Cell Biol, 2014, 47(1): 1-11. ［14］ Fillmore CM, Gupta PB, Rudnick JA, et al. Estrogen expands breast cancer stemlike cells through paracrine FGF/Tbx3 signaling［J］. Proc Natl Acad Sci USA, 2010, 107(50): 21737-21742. ［15］ Liu J, Esmailpour T, Shang X, et al. TBX3 overexpression causes mammary gland hyperplasia and increases mammary stemlike cells in an inducible transgenic mouse model［J］. BMC Dev Biol, 2011, 11: 65. ［16］ Renard CA, Labalette C, Armengol C, et al. Tbx3 is a downstream target of the Wnt/betacatenin pathway and a critical mediator of betacatenin survival functions in liver cancer［J］. Cancer Res, 2007, 67(3): 901-910. ［17］ Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer［J］. Oncogene, 2010, 29(34): 4741-4751. ［18］ Chiou SH, Wang ML, Chou YT, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem celllike properties and epithelialmesenchymal transdifferentiation［J］. Cancer Res, 2010, 70(24): 10433-10444. ［19］ Asiedu MK, BeauchampPerez FD, Ingle JN, et al. AXL induces epithelialtomesenchymal transition and regulates the function of breast cancer stem cells［J］. Oncogene, 2014, 33(10): 13161324. ［20］ Mani SA, Guo W, Liao MJ, et al. The epithelialmesenchymal transition generates cells with properties of stem cells［J］. Cell, 2008, 133(4): 704-715. ［21］ Lan L, Luo Y, Cui D, et al. Epithelialmesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells［J］. Int J Oncol, 2013, 43(1): 113-120. ［22］ Masui T, Ota I, Yook JI, et al. Snailinduced epithelialmesenchymal transition promotes cancer stem celllike phenotype in head and neck cancer cells［J］. Int J Oncol, 2014, 44(3): 693-699. ［23］ Patai AV, Molnár B, Kalmár A, et al. Role of DNA methylation in colorectal carcinogenesis［J］. Dig Dis, 2012, 30(3): 310-315. ［24］ Kang C, Song JJ, Lee J, et al. Epigenetics: an emerging player in gastric cancer［J］. World J Gastroenterol, 2014, 20(21): 6433-6447. ［25］ Kandimalla R, van Tilborg AA, Kompier LC, et al. Genomewide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTaspecific prognostic markers［J］. Eur Urol, 2012, 61(6): 1245-1256. ［26］ Li J, Weinberg MS, Zerbini L, et al. The oncogenic TBX3 is a downstream target and mediator of the TGFβ1 signaling pathway［J］. Mol Biol Cell, 2013, 24(22): 3569-3576. ［27］ Burgucu D, Guney K, Sahinturk D, et al. Tbx3 represses PTEN and is overexpressed in head and neck squamous cell carcinoma［J］. BMC cancer, 2012, 12: 481. ［28］ Renard CA, Labalette C, Armengol C, et al. Tbx3 is a downstream target of the Wnt/betacatenin pathway and a critical mediator of betacatenin survival functions in liver cancer［J］. Cancer Res, 2007, 67(3): 901-910.

[1]	Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686.
[2]	Yan Xingyu, Lian Zhenying, Diao Yutao, Liu Hongyan.BMXΔN mediates gefitinib resistance of lung cancer cells through ERK/MAPK signaling pathway[J]. Journal of International Oncology, 2021, 48(6): 328-334.
[3]	Hou Jianghou, Yao Yingjie, Zhan Xiaoyan, Yang Yimei.Regulation of EMT in lung cancer cells by interaction of Hsp90 and SIRT1[J]. Journal of International Oncology, 2021, 48(4): 200-205.
[4]	Wei Yongjian, Hu Jinjing, Li Xun.Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells[J]. Journal of International Oncology, 2021, 48(4): 216-219.
[5]	Wu Hansheng, Huang Shujie, Zhuang Weitao, Ding Yu, Gao Zhen, Qiao Guibin.m⁶A methylation modification and lung cancer[J]. Journal of International Oncology, 2021, 48(4): 225-230.
[6]	Deng Bo'er, Kong Weimin.Epigenetic research progress of endometrial cancer[J]. Journal of International Oncology, 2021, 48(3): 184-188.
[7]	Zeng Juan, Yang Xianghong.N⁶-methyladenine methylation regulators and cancer[J]. Journal of International Oncology, 2021, 48(2): 96-100.
[8]	Zhao Lili, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhang Xue, Jing Wenjun, Wei Hongmei.Effects of silencing PD-L1 expression on biological behaviors of gastric cancer cells[J]. Journal of International Oncology, 2021, 48(12): 705-710.
[9]	Liu Peipei, Yang Mengxue, Yan Xuebing.Research advances of m⁶A methylation modification in digestive system neoplasms[J]. Journal of International Oncology, 2021, 48(11): 688-692.
[10]	He Miao, Fan Kui, Cao Fang.Epigenetics and drug resistance in lung cancer[J]. Journal of International Oncology, 2021, 48(10): 622-626.
[11]	Wang Ningju, Chen Dongmei, Zhang Heng, Hu Ping, Wang Yan.Effects of targeted silencing of PRL-3 gene on proliferation, migration, invasion and epithelial-mesenchymal transition of lung cancer cells[J]. Journal of International Oncology, 2021, 48(1): 18-23.
[12]	Sang Yingbing, Liang Junqin.Epigenetic pathogenesis of cutaneous squamous cell carcinoma[J]. Journal of International Oncology, 2020, 47(9): 569-572.
[13]	Wang Lili, Zhao Song, Ouyang Mingyue, Xie Xiaodong, Xing Sining, Liu Shuo, Yu Huiying.Role of docetaxel induced polyploid tumor cells in tumor recurrence[J]. Journal of International Oncology, 2020, 47(6): 340-345.
[14]	Yin Jianyun, Wang Peiwei, Gu Jianwei.m⁶A methylation and breast cancer[J]. Journal of International Oncology, 2020, 47(12): 752-755.
[15]	Kang Ye, Li Jianyi, Yang Xianghong.Research progress of cancer stem cells in triplenegative breast cancer[J]. Journal of International Oncology, 2019, 46(6): 362-365.

Mechanism research of Tbx3 gene in tumor progression

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments